Metal Chelation Modulates Phototherapeutic Properties of Mitoxantrone-Loaded Porphyrin-Phospholipid Liposomes

被引:38
作者
Carter, Kevin A. [1 ]
Wang, Sophie [1 ]
Geng, Jumin [1 ]
Luo, Dandan [1 ]
Shao, Shuai [1 ]
Lovell, Jonathan F. [1 ]
机构
[1] SUNY Buffalo, Dept Biomed Engn, Buffalo, NY 14260 USA
基金
美国国家卫生研究院;
关键词
Chemophototherapy; porphyrin-phospholipid; liposomes; mitoxantrone; metalloporphyrins; photobleaching; tumor ablation; light-triggered; MEDIATED PHOTODYNAMIC THERAPY; DRUG-DELIVERY SYSTEMS; STEALTH LIPOSOMES; IN-VITRO; NANOPARTICLES; DOXORUBICIN; TOXICITY; COMPLEXES; SKIN; NANOTECHNOLOGY;
D O I
10.1021/acs.molpharmaceut.5b00653
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Liposomes incorporating porphyrin-phospholipid (PoP) can be formulated to release entrapped contents in response to near infrared (NIR) laser irradiation. Here, we examine effects of chelating copper or zinc into the PoP. Cu(II) and Zn(II) PoP liposomes, containing 10 molar % HPPH-lipid, exhibited unique photophysical properties and released entrapped cargo in response to NIR light. Cu-PoP liposomes exhibited minimal fluorescence and reduced production of reactive oxygen species upon irradiation. Zn-PoP liposomes retained fluorescence and singlet oxygen generation properties; however, they rapidly self-bleached under laser irradiation. Compared to the free base form, both Cu- and Zn-PoP liposomes exhibited reduced phototoxicity in mice. When loaded with mitoxantrone and administered intravenously at 5 mg/kg to mice bearing human pancreatic cancer xenografts, synergistic effects between the drug and the light treatment (for this particular dose and formulation) were realized with metallo-PoP liposomes. The drug-light-interval affected chemophototherapy efficacy and safety.
引用
收藏
页码:420 / 427
页数:8
相关论文
共 63 条
[1]   Liposomal drug delivery systems: From concept to clinical applications [J].
Allen, Theresa M. ;
Cullis, Pieter R. .
ADVANCED DRUG DELIVERY REVIEWS, 2013, 65 (01) :36-48
[2]   Advantages of liposomal delivery systems for anthracyclines [J].
Allen, TM ;
Martin, FJ .
SEMINARS IN ONCOLOGY, 2004, 31 (06) :5-15
[3]   Drug delivery systems: Entering the mainstream [J].
Allen, TM ;
Cullis, PR .
SCIENCE, 2004, 303 (5665) :1818-1822
[4]   Doxil® - The first FDA-approved nano-drug: Lessons learned [J].
Barenholz, Yechezkel .
JOURNAL OF CONTROLLED RELEASE, 2012, 160 (02) :117-134
[5]   Photobleaching of sensitisers used in photodynamic therapy [J].
Bonnett, R ;
Martínez, G .
TETRAHEDRON, 2001, 57 (47) :9513-9547
[6]   Designer nanoparticles: incorporating size, shape and triggered release into nanoscale drug carriers [J].
Caldorera-Moore, Mary ;
Guimard, Nathalie ;
Shi, Li ;
Roy, Krishnendu .
EXPERT OPINION ON DRUG DELIVERY, 2010, 7 (04) :479-495
[7]   QUENCHING OF SINGLET OXYGEN (DELTA-1(G) BY TRANSITION-METAL CHELATES [J].
CARLSSON, DJ ;
SUPRUNCH.T ;
WILES, DM .
CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE, 1974, 52 (22) :3728-3737
[8]   Porphyrin-phospholipid liposomes permeabilized by near-infrared light [J].
Carter, Kevin A. ;
Shao, Shuai ;
Hoopes, Matthew I. ;
Luo, Dandan ;
Ahsan, Bilal ;
Grigoryants, Vladimir M. ;
Song, Wentao ;
Huang, Haoyuan ;
Zhang, Guojian ;
Pandey, Ravindra K. ;
Geng, Jumin ;
Pfeifer, Blaine A. ;
Scholes, Charles P. ;
Ortega, Joaquin ;
Karttunen, Mikko ;
Lovell, Jonathan F. .
NATURE COMMUNICATIONS, 2014, 5
[9]   Quantitative structure - property relationship modeling of remote liposome loading of drugs [J].
Cern, Ahuva ;
Golbraikh, Alexander ;
Sedykh, Aleck ;
Tropsha, Alexander ;
Barenholz, Yechezkel ;
Goldblum, Amiram .
JOURNAL OF CONTROLLED RELEASE, 2012, 160 (02) :147-157
[10]   Rate of biodistribution of STEALTH® liposomes to tumor and skin:: influence of liposome diameter and implications for toxicity and therapeutic activity [J].
Charrois, GJR ;
Allen, TM .
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2003, 1609 (01) :102-108